Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

News SummaryMost relevantAll newsSector newsTweets 

Pressure Biosciences : Pressure BioSciences, Inc. Upgraded by EdgeWater Research Partners LLC

share with twitter share with LinkedIn share with facebook
share via e-mail
12/27/2006 | 04:48pm CET

Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that in an update to an initial research report on the Company, EdgeWater Research Partners LLC (?EdgeWater?) has upgraded PBI's rating from a 4 to a 6 and re-established a 12-18 month price target. Of the 20 companies currently covered by EdgeWater, only one has a rating greater than 6.

Copies of the updated and initial research reports on PBI can be obtained free of charge by contacting Mr. David Lavigne at EdgeWater (www.edgewaterresearch.com or 303-593-2877).

Analyst Coverage Disclaimer

Pressure BioSciences is announcing the availability of EdgeWater's updated research report solely for convenience. Any opinions, estimates, or forecasts regarding Pressure BioSciences' historical or predicted performance or operations, including predictions of stock price, made by EdgeWater are theirs alone and do not represent opinions, judgments, estimates, or forecasts of Pressure BioSciences or its management. Pressure BioSciences does not endorse, adopt, or concur with information, conclusions, or recommendations in either EdgeWater's initial or updated research reports on the Company. Pressure BioSciences subscribes for EdgeWater's newsletter and research information, and has purchased EdgeWater's research reports. For the past two years, Pressure BioSciences has paid a fee of $8000 to attend and present at EdgeWater's fall Micro/Small Cap Conference for Investment Professionals.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended September 30, 2006; in the Company's Annual Report on Form 10-KSB, as amended, for the year ended December 31, 2005; and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website http://www.pressurebiosciences.com

© Business Wire 2006
share with twitter share with LinkedIn share with facebook
share via e-mail
02/09 PRESSURE BIOSCIENCES : Ramps Up Commercialization of Next-Generation Instrument ..
02/08 PRESSURE BIOSCIENCES : Discusses Research Market, Goals and Milestones for First..
02/02 PRESSURE BIOSCIENCES : Achieves CE Marking for its Next Generation Sample Prepar..
01/24 PRESSURE BIOSCIENCES, INC. : to Present at RedChip's Global Online Growth Confer..
01/10 PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. to Present at the 2017 Bio..
01/10 PRESSURE BIOSCIENCES, INC. : to Present at the 2017 Biotech Showcase
01/03 PRESSURE BIOSCIENCES : NetworkNewsBreaks – Pressure BioSciences, Inc. (PBI..
2016 PRESSURE BIOSCIENCES, INC. (OTCMKTS : PBIO) Files An 8-K Submission of Matters t..
2016 PRESSURE BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (..
2016 PRESSURE BIOSCIENCES, INC. : Well Positioned to Play Important Role in US's $1.8..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21DJMEDTRONIC : Earnings Fall, Sales Rise -- Update
02/21 MEDTRONIC : sales, profit beat estimates; shares rise
02/21DJMEDTRONIC : Earnings Fall, Sales Rise
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
More sector news : Medical Equipment, Supplies & Distribution - NEC
Income Statement Evolution
More Financials
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Consensus details
Richard T. Schumacher President, CEO, CFO, Secretary & Treasurer
Jeffrey N. Peterson Chairman
Edmund Y. Ting Senior Vice President-Engineering
Vito J. Mangiardi Independent Director
Kevin A. Pollack Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC10.74%108 306
C R BARD INC7.90%17 461
More Results